Editor’s Pick
Oct 29, 2025
Coverage Universe
Publishing biotech research since 2019. Sponsored and unsponsored.
We focus on micro-cap and small-cap names.
We distill complicated biotech ideas into an understandable narrative.
Editor's Picks
Editor’s Pick
Jul 17, 2025
Ovid and Xenon: Too Early to Draw Parallels?
$DCTH · $DRUG · $NKTR · $OVID · $PCSA · $SLNO · $XENE
Read full piece →Editor’s Pick
Dec 8, 2024
All Coverage
Sorted by date, newest first
Jul 14, 2026
2H2026 Catalyst Cluster
$ABOS, $EPRX, $MSLE, $OVID, $PMN, $XENE
Read piece →May 22, 2026
Protara at a Crossroads
Read piece →Apr 27, 2026
Equillium’s Turnaround: AHR, Abivax, and ADAR1
Read piece →Feb 20, 2026
Predicting Protara: Impending Data at Next Week’s ASCO-GU
Read piece →Jan 30, 2026
From Aduhelm’s Ashes: Two Affordable Alzheimer Names Targeting Toxic Oligomers
Read piece →Jan 9, 2026
Prediction Payoff: Ventyx Acquired, Plus Updates On Entera & Gain
Read piece →Jan 2, 2026
Pipelines, Partnerships and Predictions For 2026
Read piece →Nov 18, 2025
Could A New Narrative Be Forming? Protara & LMs
Read piece →Oct 29, 2025